Daxor Corporation (DXR) vs Microbot Medical Inc. (MBOT)
Daxor Corporation and Microbot Medical Inc. are both Medical Instruments & Supplies companies. Microbot Medical Inc. is the larger, with a market value of $88.0M against $66.5M — 1.3× the size. Microbot Medical Inc. has negative trailing earnings, so its P/E is not meaningful; Daxor Corporation trades at 5.1×. Daxor Corporation grew revenue faster over the last twelve months: −52.1% against −59.1%. Daxor Corporation has the higher net margin (−251.9% vs −3,955.2%) and the higher return on invested capital (0.00% vs −850.5%). Across the 16 metrics below, Daxor Corporation leads on 12 and Microbot Medical Inc. on 4.
Valuation
Profitability
| Metric | DXR | MBOT | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 0.00% | (166.30%) | 54.62% |
| Operating margin | 0.00% | (4,480.03%) | 1.64% |
| Net margin | (251.91%) | (3,955.22%) | 0.00% |
| Free cash flow margin | 224.51% | (4,340.11%) | 1.61% |
| Return on equity | 37.62% | (32.91%) | 0.00% |
| Return on assets | 35.90% | (30.68%) | 0.00% |
| Return on invested capital | 0.00% | (850.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack